[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

TR200000148T2 - 1-(4-Karbazoliloksi)-3-(2-metoksifenoksi) etilamino)-2-propanol' ün modifikasyonu, gerekli proses ve farmasötik bileşimler. - Google Patents

1-(4-Karbazoliloksi)-3-(2-metoksifenoksi) etilamino)-2-propanol' ün modifikasyonu, gerekli proses ve farmasötik bileşimler.

Info

Publication number
TR200000148T2
TR200000148T2 TR2000/00148T TR200000148T TR200000148T2 TR 200000148 T2 TR200000148 T2 TR 200000148T2 TR 2000/00148 T TR2000/00148 T TR 2000/00148T TR 200000148 T TR200000148 T TR 200000148T TR 200000148 T2 TR200000148 T2 TR 200000148T2
Authority
TR
Turkey
Prior art keywords
carbazoliloxy
methoxyphenoxy
ethylamino
propanol
pharmaceutical compositions
Prior art date
Application number
TR2000/00148T
Other languages
English (en)
Inventor
Reinholz Erhard
Beyer Peter
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of TR200000148T2 publication Critical patent/TR200000148T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Elimizdeki bulus 1-(4-karbazoliloksi) -3-(2-(2-metoksifenoksi)etilamino)-2-propanol' ün (karvedilol) termodinamik açidan kararli sekilde yeni bir modifikasyonu, farmakolojik olarak kabul edilebilir tuzlari ya da bunlarin optik olarak aktif sekilleri, hazirlanmasi için prosesler ve bunu içeren farmasötik bilesimlerle ilgilidir.
TR2000/00148T 1997-07-22 1998-07-18 1-(4-Karbazoliloksi)-3-(2-metoksifenoksi) etilamino)-2-propanol' ün modifikasyonu, gerekli proses ve farmasötik bileşimler. TR200000148T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97112491A EP0893440A1 (en) 1997-07-22 1997-07-22 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it

Publications (1)

Publication Number Publication Date
TR200000148T2 true TR200000148T2 (tr) 2000-07-21

Family

ID=8227094

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00148T TR200000148T2 (tr) 1997-07-22 1998-07-18 1-(4-Karbazoliloksi)-3-(2-metoksifenoksi) etilamino)-2-propanol' ün modifikasyonu, gerekli proses ve farmasötik bileşimler.

Country Status (32)

Country Link
EP (2) EP0893440A1 (tr)
JP (1) JP2001510824A (tr)
KR (1) KR100336229B1 (tr)
CN (1) CN1125047C (tr)
AR (1) AR015133A1 (tr)
AT (1) ATE236123T1 (tr)
AU (1) AU740453B2 (tr)
BR (1) BR9810776A (tr)
CA (1) CA2296637C (tr)
CZ (1) CZ296947B6 (tr)
DE (1) DE69812964T2 (tr)
DK (1) DK1000027T3 (tr)
ES (1) ES2195366T3 (tr)
HK (1) HK1029339A1 (tr)
HR (1) HRP980406A2 (tr)
HU (1) HUP0003198A3 (tr)
IL (1) IL133677A (tr)
MA (1) MA26523A1 (tr)
MY (1) MY117734A (tr)
NO (1) NO313588B1 (tr)
NZ (1) NZ502136A (tr)
PE (1) PE96999A1 (tr)
PL (1) PL191602B1 (tr)
PT (1) PT1000027E (tr)
RU (1) RU2202542C2 (tr)
SI (1) SI1000027T1 (tr)
TR (1) TR200000148T2 (tr)
TW (1) TW505631B (tr)
UY (1) UY25108A1 (tr)
WO (1) WO1999005105A1 (tr)
YU (1) YU2200A (tr)
ZA (1) ZA986475B (tr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2402336C (en) * 2000-04-03 2008-03-11 F. Hoffmann-La Roche Ag Concentrated solutions of carvedilol
EP1655285A1 (en) * 2000-06-28 2006-05-10 Teva Pharmaceutical Industries Ltd. Method for preparation of a crystalline form of carvedilol (form II)
IL153688A0 (en) 2000-06-28 2003-07-06 Teva Pharma Carvedilol
EP1406614B1 (en) * 2001-07-13 2006-06-07 Smithkline Beecham Corporation Carvedilol polymorph
EP1929998A3 (en) 2001-09-21 2008-11-26 Egalet A/S Controlled release solid dispersions of carvedilol
RU2308449C2 (ru) * 2001-09-28 2007-10-20 Ф.Хоффманн-Ля Рош Аг Псевдополиморфные формы карведилола
CN1298322C (zh) * 2002-01-15 2007-02-07 特瓦制药工业有限公司 卡维地洛的结晶固体及其制备方法
CA2483054A1 (en) * 2002-04-30 2003-11-13 Sb Pharmco Puerto Rico Inc. Carvedilol monocitrate monohydrate
EP1539140A4 (en) 2002-06-27 2005-12-07 Sb Pharmco Inc CARVEDILOLHYDOBROMID
BR0312102A (pt) 2002-06-27 2007-05-29 Sb Pharmco Inc sais de fosfato de carvedilol e/ou seus solvatos, composições correspondentes, e/ou métodos de tratamento
US20040151772A1 (en) 2002-11-08 2004-08-05 Egalet A/S Controlled release carvedilol compositions
DE602004031096D1 (de) 2003-03-26 2011-03-03 Egalet As Morphin-system mit kontrollierter freisetzung
WO2004094378A1 (en) * 2003-04-21 2004-11-04 Matrix Laboratories Ltd Process for the preparation of carvedilol form-ii
SI21616A (sl) * 2003-09-02 2005-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove kristalne oblike karvedilola
EP1686986A4 (en) * 2003-11-25 2009-05-27 Sb Pharmco Inc CARVEDILOL SALTS, CORRESPONDING COMPOSITIONS, METHODS OF ADMINISTRATION AND / OR TREATMENT
DK1838670T3 (da) * 2004-12-09 2010-03-01 Zach System Spa Fremgangsmåde til fremstilling af carvedilol og dets enantiomere
EP1781611A1 (en) * 2005-06-09 2007-05-09 Teva Pharmaceutical Industries Ltd. Crystalline forms of carvedilol and processes for their preparation
US8022094B2 (en) 2006-06-28 2011-09-20 Teva Pharmaceutical Industries Ltd. Carvedilol phosphate
US20080249317A1 (en) * 2007-04-04 2008-10-09 Apotex Inc. Novel amorphous form of carvedilol phosphate and processes for the preparation thereof
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
WO2010089132A1 (en) 2009-02-06 2010-08-12 Egalet A/S Immediate release composition resistant to abuse by intake of alcohol
WO2010149169A2 (en) 2009-06-24 2010-12-29 Egalet A/S Controlled release formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3319027A1 (de) * 1983-05-26 1984-11-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten

Also Published As

Publication number Publication date
YU2200A (sh) 2002-03-18
EP1000027B1 (en) 2003-04-02
NO313588B1 (no) 2002-10-28
ES2195366T3 (es) 2003-12-01
CA2296637C (en) 2005-11-15
ATE236123T1 (de) 2003-04-15
AR015133A1 (es) 2001-04-18
CZ2000221A3 (cs) 2000-05-17
MY117734A (en) 2004-07-31
PE96999A1 (es) 1999-10-12
BR9810776A (pt) 2000-09-19
CA2296637A1 (en) 1999-02-04
EP0893440A1 (en) 1999-01-27
HK1029339A1 (en) 2001-03-30
SI1000027T1 (en) 2003-10-31
HUP0003198A3 (en) 2002-10-28
DE69812964D1 (de) 2003-05-08
KR20010022097A (ko) 2001-03-15
MA26523A1 (fr) 2004-12-20
PT1000027E (pt) 2003-07-31
RU2202542C2 (ru) 2003-04-20
IL133677A (en) 2004-06-01
NO20000301L (no) 2000-01-21
NZ502136A (en) 2002-05-31
HRP980406A2 (en) 1999-04-30
JP2001510824A (ja) 2001-08-07
NO20000301D0 (no) 2000-01-21
PL338432A1 (en) 2000-11-06
CZ296947B6 (cs) 2006-08-16
AU8631998A (en) 1999-02-16
PL191602B1 (pl) 2006-06-30
DE69812964T2 (de) 2004-03-04
WO1999005105A1 (en) 1999-02-04
TW505631B (en) 2002-10-11
DK1000027T3 (da) 2003-07-21
KR100336229B1 (ko) 2002-05-09
EP1000027A1 (en) 2000-05-17
CN1264366A (zh) 2000-08-23
HUP0003198A2 (en) 2001-03-28
ZA986475B (en) 2000-01-21
UY25108A1 (es) 2000-12-29
AU740453B2 (en) 2001-11-01
IL133677A0 (en) 2001-04-30
CN1125047C (zh) 2003-10-22

Similar Documents

Publication Publication Date Title
TR200000148T2 (tr) 1-(4-Karbazoliloksi)-3-(2-metoksifenoksi) etilamino)-2-propanol' ün modifikasyonu, gerekli proses ve farmasötik bileşimler.
NO20015226L (no) Tri-aryl syrederivater som PPAR reseptor ligander, farmasoytisk sammensetning omfattende samme og anvendelse av samme for fremstilling av medikament.
ES2080297T3 (es) Derivados 17-g(b)-sustituido-4-aza-5g(a)-androstan-3-ona y procedimiento de preparacion de estos.
TR199800585T2 (tr) COX-2 Inhibitörleri Olarak (Metilsülfonil)Fenil-2-(5H)-Furanonlar.
TR200101961T2 (tr) 1,2-halkalı kinolin türevleri
CA2356310A1 (en) External preparations containing a basic drug
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
FI963169A (fi) Enkefalinaasin ja ACE:n inhibittoreina käyttökelpoisia uusia merkaptoasetyyliamido-1,3,4,5-tetrahydrobents/c/-atsepin-3-onidisulfidijohdannaisia
BR9915735A (pt) Antagonistas receptores de ccr-3 de piperidina
CA2219359A1 (en) Hydantoin derivatives as intermediates for pharmaceutical active compounds
DK0756602T3 (da) CCK- eller gastrin-modulerende 5-heterocyclo-1,5-benzodiazepiner
TR200001909T2 (tr) Matris metaloprotez inhibitörleri.
MX9301112A (es) Derivados de indol.
ATE125541T1 (de) Reine kristalline form von rifapentin.
FI853763L (fi) 1,3-dimetyl-1h-purin-2,6-dioner, som innehaoller 1h-indol-3-yl.
TR199802552T2 (tr) 5-HT-2C Reseptör karsitlari olarak faydali indolin türevleri.
PT984922E (pt) Preparacao de composto de tri-iodo benzeno
DK0871612T3 (da) Kondenserede isoindoloner som proteinkinase C-inhibitorer
DK0775113T3 (da) N-substituerede azabicycloheptan-derivater som neuroleptika osv.
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.
YU43499A (sh) Kristalna hidratovana natrijumova so (e)-4,6-dihloro-3- (2-okso-1-fenilpirolidin-3-iliden metil)-1h-indol-2- karboksilne kiseline
BG100697A (en) Fluoropropylthiazoline derivative and herbicide
TR200103169T2 (tr) 1,5-Benzodiazepin türevleri
AU567498B2 (en) 5-phenyl-1h-2,3-dihydro-1,4-benzodiazepine derivatives.
BR9813533A (pt) "2,4-diamino-1,3,5- triazinas substituìdas"